Can an antidepressant stop migraines before they start?

NCT ID NCT07385755

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether desvenlafaxine, a drug typically used for depression, can help prevent migraines in adults who have frequent attacks. Researchers will compare the drug to a placebo in 440 participants over 12 weeks. The goal is to see if it reduces the number of migraine days per month.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Desvenlafaxine

What this could lead to

If it works, this could provide a new option for preventing frequent migraines, reducing the number of headache days per month.

What could go wrong

This is a mid-stage trial with no phase designation, so results are not yet confirmed. Desvenlafaxine may cause side effects like nausea or dizziness, and it might not work better than a placebo.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MIGRAINE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

migraine disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology

    Wuhan, Hubei, 430000, China